Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine vs placebo to prevent acute reduction in renal function after primary angioplasty (NoVARA)
2010-022952-22Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in contrast-induced nephropathy (CIN) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Development of contrast-induced acute renal failure. Started Dec 2010; status: active.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2010-022952-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022952-22.